'Complete resection' presentation slideshows

SURGICAL APPROACH TO MEDIASTINAL LESIONS

SURGICAL APPROACH TO MEDIASTINAL LESIONS. DR. KAMIL KAYNAK ISTANBUL UNIVERSITY CERRAHPASA MEDICAL FACULTY THORACIC SURGERY DEPARTMENT. Lymphadenomegaly is the most frequent lesion seen in mediastinum. LAM of Mediastinum. An enlarged lymph node can not always be accepted as pathological

1.52k views • 66 slides

Surgical Indications and techniques for lung metastases

The 53 rd International Congress of the Egyptian Society of Chest diseases and tuberculosis March 2012 Cairo. Surgical Indications and techniques for lung metastases. ALAIN BISSON Thoracic Surgery and Lung Transplantation HOPITAL FOCH PARIS. Surgery in Lung metastases.

670 views • 37 slides

Adrenal Carcinoma

511 views • 36 slides

Resection For Lung Metastases

Resection For Lung Metastases. M62 Coloproctology Course. Lung Metastases. 1 st resection of a single metastases discovered during the excision of a chest wall sarcoma Elective surgery occasionally offered to selected patients with single metastases and long disease free interval

533 views • 33 slides

Role of Chemotherapy For Endometrial Carcinoma

IGCS council, GCIG executive board Sapporo Railway Hospital Vice-director Sapporo Japan. Role of Chemotherapy For Endometrial Carcinoma. Satoru Sagae MD PhD. IGCS 10,2006. Endometrial Cancer - Treatment Plan. Surgical Staging. Low Risk IA: G1-2 No treatment. Intermediate Risk

864 views • 28 slides

Superior Sulcus Resection

Superior Sulcus Resection. G. Alexander Patterson, MD Evarts A. Graham Professor of Surgery Chief, Division of Cardiothoracic Surgery. Superior Sulcus Tumors. Evaluated 116 patients Eligible 101 patients Completed Induction Rx 93% Thoractomy 81% 1 operative mortality.

491 views • 28 slides

546 views • 28 slides

Superior Sulcus Resection

Superior Sulcus Resection. G. Alexander Patterson, MD Evarts A. Graham Professor of Surgery Chief, Division of Cardiothoracic Surgery. Superior Sulcus Tumors. Evaluated 116 patients Eligible 101 patients Completed Induction Rx 93% Thoractomy 81% 1 operative mortality.

570 views • 28 slides

Testis Cancer The Management of Residual Masses Post-chemotherapy

Testis Cancer The Management of Residual Masses Post-chemotherapy . Dr Manish I. Patel Urologic Oncologist Westmead Hospital / University of Sydney. Questions to be Answered. Do all masses have to be resected or can the histology be accurately predicted?

487 views • 25 slides

Cortical dysplasia

Cortical dysplasia. ??? R3 ???. Cortical dysplasia. Disturbed development of cells that normally participate in formation of the cerebral cortex ? Disorders of cortical development known causes : intrauterine infection & ischemia, and chromosomal mutations

1.08k views • 25 slides

Familial Gynaecological Cancers

Familial Gynaecological Cancers. A/Prof Andreas Obermair Gynaecological Oncologist RBWH, Greenslopes Private Hospital www.obermair.info. Major Known Mutations. BRCA1 BRCA2 Mismatch Repair Genes Other undiscovered. Hereditary Ovarian Cancer. BRCA1 life-time risk 16-54%

512 views • 24 slides

Connective Tissue Oncology Society November 17 th , 2012 Prague, Czech Republic

448 views • 20 slides

Local Recurrence Growth Rate Predicts Outcome In Locally Recurrent Retroperitoneal Liposarcoma

Local Recurrence Growth Rate Predicts Outcome In Locally Recurrent Retroperitoneal Liposarcoma. James Park, MD, Li-Xuan Qin, PhD, Francesco Prete, MD Murray Brennan, MD, Samuel Singer, MD. Background: Retroperitoneal Liposarcoma Retroperitoneal sarcoma (RPS) 15% of soft tissue sarcomas (STS) 1

390 views • 20 slides

Local Recurrence Growth Rate Predicts Outcome In Locally Recurrent Retroperitoneal Liposarcoma

Local Recurrence Growth Rate Predicts Outcome In Locally Recurrent Retroperitoneal Liposarcoma. James Park, MD, Li-Xuan Qin, PhD, Francesco Prete, MD Murray Brennan, MD, Samuel Singer, MD. Background: Retroperitoneal Liposarcoma Retroperitoneal sarcoma (RPS) 15% of soft tissue sarcomas (STS) 1

315 views • 20 slides

Presented By Alexander Eggermont at 2014 ASCO Annual Meeting

Ipilimumab Versus Placebo After <br />Complete Resection of Stage III Melanoma: <br />Initial Efficacy and Safety Results from the EORTC 18071 Phase III Trial. Presented By Alexander Eggermont at 2014 ASCO Annual Meeting. Slide 2. Presented By Alexander Eggermont at 2014 ASCO Annual Meeting.

474 views • 18 slides

Nuyttens et al. Cancer 2000

EORTC 62991-22998: Phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis.

260 views • 17 slides

POSTER VIEWING OF SESSION 6

POSTER VIEWING OF SESSION 6. Treatment for sacral chordoma; surgery or carbon ion radiotherapy.

248 views • 14 slides

POSTER VIEWING OF SESSION 6

POSTER VIEWING OF SESSION 6. Treatment for sacral chordoma; surgery or carbon ion radiotherapy.

251 views • 14 slides

Barry W. Feig, M.D. Robert S. Benjamin, M.D. The SARCOMA Center

The Connective Tissue Oncology Society. Surgical Treatment of GIST post Imatinib. Barry W. Feig, M.D. Robert S. Benjamin, M.D. The SARCOMA Center. Chemotherapy + Surgery CR Chemotherapy CR Partial Response Stable Disease. SOFT TISSUE SARCOMAS 1971-1977

311 views • 11 slides

ABSTRACT

ABSTRACT. POST-OPERATIVE. SECOND SURGERY. This report concerned a young patient with growing teratoma syndrome who required complete resection. Residual disease is the commonest suspicion following fertility conserving surgery for immature teratoma of ovary in a young woman.

137 views • 1 slides